These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27144659)

  • 1. Dual Incorporation of the in vitro Data (IC50) and in vivo (Cmax) Data for the Prediction of Area Under the Curve (AUC) for Statins using Regression Models Developed for Either Pravastatin or Simvastatin.
    Srinivas NR
    Drug Res (Stuttg); 2016 Aug; 66(8):402-6. PubMed ID: 27144659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited Sampling Strategy for the Prediction of Area Under the Curve (AUC) of Statins: Reliability of a Single Time Point for AUC Prediction for Pravastatin and Simvastatin.
    Srinivas NR
    Drug Res (Stuttg); 2016 Feb; 66(2):82-93. PubMed ID: 26011815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
    Jacobson TA
    Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ; Kantola T; Kivistö KT
    Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus.
    Kovarik JM; Hartmann S; Hubert M; Berthier S; Schneider W; Rosenkranz B; Rordorf C
    J Clin Pharmacol; 2002 Feb; 42(2):222-8. PubMed ID: 11831546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
    Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
    Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions.
    Derks M; Abt M; Phelan M; Turnbull L; Meneses-Lorente G; Bech N; White AM; Parr G
    J Clin Pharmacol; 2010 Oct; 50(10):1188-201. PubMed ID: 20489031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin.
    Mazzu AL; Lasseter KC; Shamblen EC; Agarwal V; Lettieri J; Sundaresen P
    Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers.
    Offman E; Davidson M; Nilsson C
    J Clin Lipidol; 2017; 11(3):739-748. PubMed ID: 28506390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics.
    Becquemont L; Neuvonen M; Verstuyft C; Jaillon P; Letierce A; Neuvonen PJ; Funck-Brentano C
    Clin Pharmacol Ther; 2007 May; 81(5):679-84. PubMed ID: 17301736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins Reduce Lipopolysaccharide-Induced Cytokine and Inflammatory Mediator Release in an In Vitro Model of Microglial-Like Cells.
    McFarland AJ; Davey AK; Anoopkumar-Dukie S
    Mediators Inflamm; 2017; 2017():2582745. PubMed ID: 28546657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin.
    Nezasa K; Higaki K; Matsumura T; Inazawa K; Hasegawa H; Nakano M; Koike M
    Drug Metab Dispos; 2002 Nov; 30(11):1158-63. PubMed ID: 12386119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Fostamatinib on the Pharmacokinetics of Oral Contraceptive, Warfarin, and the Statins Rosuvastatin and Simvastatin: Results From Phase I Clinical Studies.
    Martin P; Gillen M; Ritter J; Mathews D; Brealey C; Surry D; Oliver S; Holmes V; Severin P; Elsby R
    Drugs R D; 2016 Mar; 16(1):93-107. PubMed ID: 26748647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Effects of Statins on A549 Nonsmall-Cell Lung Cancer Cell Line Lipids Using Fourier Transform Infrared Spectroscopy: Rosuvastatin Stands Out.
    Aksoy HN; Ceylan C
    Lipids; 2021 May; 56(3):289-299. PubMed ID: 33611813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.
    Saito M; Hirata-Koizumi M; Urano T; Miyake S; Hasegawa R
    J Clin Pharm Ther; 2005 Feb; 30(1):21-37. PubMed ID: 15659001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites.
    Zhang T
    Eur J Pharm Sci; 2015 Sep; 77():216-29. PubMed ID: 26116278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin: new preparation. Opt for statins with evidence of efficacy on clinical outcome.
    Prescrire Int; 2004 Aug; 13(72):132-4. PubMed ID: 15532136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not all statins interfere with clopidogrel during antiplatelet therapy.
    Mach F; Senouf D; Fontana P; Boehlen F; Reber G; Daali Y; de Moerloose P; Sigwart U
    Eur J Clin Invest; 2005 Aug; 35(8):476-81. PubMed ID: 16101667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
    Schachter M
    Fundam Clin Pharmacol; 2005 Feb; 19(1):117-25. PubMed ID: 15660968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.